View in EDS

High Dose Atorvastatin Decreases Cellular Markers of Immune Activation Without Affecting HIV-1 RNA Levels: Results of a Double-blind Randomized Placebo Controlled Clinical Trial.

Saved in:
Bibliographic Details
Title: High Dose Atorvastatin Decreases Cellular Markers of Immune Activation Without Affecting HIV-1 RNA Levels: Results of a Double-blind Randomized Placebo Controlled Clinical Trial.
Authors: Ganesan, Anuradha1,2, Crum-Cianflone, Nancy2,3, Higgins, Jeanette4, Qin, Jing5, Rehm, Catherine6, Metcalf, Julia7, Brandt, Carolyn3, Vita, Jean1, Decker, Catherine F.1, Sklar, Peter8,9, Bavaro, Mary3, Tasker, Sybil10, Follmann, Dean5, Maldarelli, Frank11
Source: Journal of Infectious Diseases. 2011, Vol. 203 Issue 6, p756-764. 9p.
Database: Environment Complete
Description
ISSN:00221899
DOI:10.1093/infdis/jiq115